Skip to main content

Josep Castellví Vives

Institutions of which they are part

Senior researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Josep Castellví Vives

Institutions of which they are part

Senior researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Patologia molecular translacional

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Cleofé Romagosa Pérez-Portabell, Maria Rosa Somoza Lopez de Haro, Jordi Temprana Salvador, Teresa Moline Marimon, Jessica Camacho Soriano, Carmela Iglesias i Felip, Josep Castellví Vives, Elena Muro Blanc, Marta Cano Galietero, Elena Antima Martinez Saez, Javier Hernandez Losa, Marta Sese Faustino, Vicente Peg Camara, Irene Sansano Valero, Trond Aasen , Stefan Hummer
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 40000
Reference: 2021 SGR 01138
Duration: 01/01/2022 - 30/06/2025

Enhancing CD8+ Resident Memory T cell function to control and eliminate viral reservoirs

IP: Meritxell Genesca Ferrer
Collaborators: Vicente Descalzo Jorro, Josep Castellví Vives, Laura Mañalich Barrachina
Funding agency: Instituto de Salud Carlos III
Funding: 171820
Reference: PI20/00160
Duration: 01/01/2021 - 30/06/2025

New therapeutic approaches in head and neck cancer

IP: Matilde Lleonart Pajarin
Collaborators: Irene Braña Garcia, Yoelsis Garcia Mayea, Jordi Temprana Salvador, Angel García Jiménez, Sergio Benavente Norza, Josep Castellví Vives, Laia Josa Culleré, Marina Bataller Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 183920
Reference: PI20/00556
Duration: 01/01/2021 - 30/06/2025

Targeting the MNK/eIF4E axis in cancer: a rational approach to enhance tumor sensitivity to chemo- and immunotherapy.

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Teresa Moline Marimon, Josep Castellví Vives, Marta Sese Faustino, Stefan Hummer
Funding agency: Instituto de Salud Carlos III
Funding: 123420
Reference: PI20/01687
Duration: 01/01/2021 - 31/12/2023

Related news

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Related professionals

Laura Martin Fernandez

Laura Martin Fernandez

Postdoctoral researcher
Transfusional Medicine
Read more
Maria Dolores Castilllo Cejas

Maria Dolores Castilllo Cejas

Predoctoral researcher
Physiology and Pathophysiology of the Digestive Tract
Read more
Carlos Serrano Burgos

Carlos Serrano Burgos

Research assistant
Biomedical Research in Urology
Read more
Marta Martinez Oliva

Marta Martinez Oliva

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.